切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2024, Vol. 18 ›› Issue (06) : 704 -708. doi: 10.3877/cma.j.issn.1674-3946.2024.06.029

综述

营养与炎症指标在可切除胰腺癌中的研究进展
付成旺1, 杨大刚2,(), 王榕3, 李福堂4   
  1. 1. 550004 贵阳,贵州医科大学临床医学院
    2. 550004 贵阳,贵州医科大学临床医学院;550004 贵阳,贵州医科大学附属医院
    3. 550004 贵阳,贵州医科大学公共卫生与健康学院
    4. 550004 贵阳,贵州医科大学附属白云医院
  • 收稿日期:2023-11-04 出版日期:2029-12-26
  • 通信作者: 杨大刚

Research progress of nutritional and inflammatory markers in resectable pancreatic cancer

Chengwang Fu1, Dagang Yang2,(), Rong Wang3, Futang Li4   

  1. 1. Clinical Medical College, Guizhou Medical University, Guiyang Guizhou Province 550004, China
    2. Clinical Medical College, Guizhou Medical University, Guiyang Guizhou Province 550004, China;Affiliated Hospital of Guizhou Medical University, Guiyang Guizhou Province 550004, China
    3. School of Public Health and Health, Guizhou Medical University, Guiyang Guizhou Province 550004, China
    4. Baiyun Hospital Affiliated to Guizhou Medical University, Guiyang Guizhou Province 550004, China
  • Received:2023-11-04 Published:2029-12-26
  • Corresponding author: Dagang Yang
  • Supported by:
    2021 Guizhou Provincial Health Commission Fund Science and Technology Fund Project(gzwkj2021-174)
引用本文:

付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.

Chengwang Fu, Dagang Yang, Rong Wang, Futang Li. Research progress of nutritional and inflammatory markers in resectable pancreatic cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 704-708.

胰十二指肠切除术是可切除胰腺癌患者首选的治疗方式,但术式复杂,并发症多,影响患者预后。近年来,国内外研究对可切除胰腺癌患者术后并发症发生及预后的预测作出了探索,其中又以营养与炎症标志物研究相对集中,营养与炎症可通过影响肿瘤患者术前营养状况及肿瘤微环境,进而影响患者术后并发症发生及预后。本文通过检索国内外相关文献并加以分析,以期能够为临床工作者提供参考。

Pancreaticoduodenectomy is the preferred treatment for patients with resectable pancreatic cancer, but its operation is complicated and has many complications, which affects the prognosis of patients. In recent years, domestic and foreign studies have explored the prediction of postoperative complications and prognosis of patients with resectable pancreatic cancer, and the studies on nutrition and inflammation markers are relatively concentrated. Nutrition and inflammation can affect the postoperative complications and prognosis of patients by affecting the preoperative nutritional status and tumor microenvironment. In this paper, the relevant literature at home and abroad is searched and analyzed to get a summary, in order to provide references for clinical workers.

[1]
Bengtsson AAndersson RAnsari D. The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data[J]. Sci Rep202010(1): 16425.
[2]
Zindel JKubes P. DAMPs,PAMPs,and LAMPs in Immunity and Sterile Inflammation[J]. Annu Rev Pathol202015: 493-518.
[3]
Murata M. Inflammation and cancer[J]. Environ Health Prev Med201823(1): 50.
[4]
Öhlund DHandly-Santana ABiffi G,et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer[J]. J Exp Med2017214(3): 579-596.
[5]
Dougan SK. The Pancreatic Cancer Microenvironment[J]. Cancer J201723(6): 321-325.
[6]
Rihawi KRicci ADRizzo A,et al. Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications[J]. Int J Mol Sci202122(8): 3805.
[7]
石浩伟,郝少龙,纪宇,等. 低氧微环境对胰腺癌影响的研究进展[J/CD]. 中华普外科手术学杂志(电子版)202115(03): 351-354.
[8]
Zhou ZQPang SYu XC,et al. Predictive Values of Postoperative and Dynamic Changes of Inflammation Indexes in Survival of Patients with Resected Colorectal Cancer[J]. Curr Med Sci201838(5): 798-808.
[9]
Yang JGuo XWu T,et al. Prognostic significance of inflammation-based indexes in patients with stage III/IV colorectal cancer after adjuvant chemoradiotherapy[J]. Medicine(Baltimore)201998(6): e14420.
[10]
Müller PCProbst PMoltzahn F,et al. Short- versus long-term complementary nutritional support via needle catheter jejunostomy after pancreaticoduodenectomy: Study protocol of a randomized controlled trial[J]. Int J Surg Protoc20173: 1-6.
[11]
Afaneh CGerszberg DSlattery E,et al. Pancreatic cancer surgery and nutrition management: a review of the current literature[J]. Hepatobiliary Surg Nutr20154(1): 59-71.
[12]
Slotwinski ROlszewski WLSlotkowski M,et al. Can the interleukin-1 receptor antagonist(IL-1ra)be a marker of anti-inflammatory response to enteral immunonutrition in malnourished patients after pancreaticoduodenectomy?[J]. JOP20078(6): 759-769.
[13]
Yang HFeng YSun X,et al. Enteral versus parenteral nutrition: effect on intestinal barrier function[J]. Ann NY Acad Sci20091165: 338-346.
[14]
Onodera TGoseki NKosaki G. [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients][J]. Nihon Geka Gakkai Zasshi198485(9): 1001-1005.
[15]
Okadome KBaba YYagi T,et al. Prognostic Nutritional Index,Tumor-infiltrating Lymphocytes,and Prognosis in Patients with Esophageal Cancer[J]. Ann Surg2020271(4): 693-700.
[16]
Pan YMa YDai G. The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy[J]. Nutrients202315(19): 4290.
[17]
Wang XLiu XDai H,et al. Peripheral blood nutrient indices as biomarkers for anti‑PD‑1 therapy efficacy and prognosis in patients with advanced gastric cancer[J]. Oncol Lett202326(3): 397.
[18]
Feng HXu FZhao Y,et al. Prognostic value of combined inflammatory and nutritional biomarkers in HCC within the Milan criteria after hepatectomy[J]. Front Oncol202212: 947302.
[19]
Li KZhao FGuo Y,et al. Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center,retrospective study[J]. BMC Cancer202323(1): 797.
[20]
Li WLi MWang T,et al. Controlling Nutritional Status(CONUT)score is a prognostic factor in patients with resected breast cancer[J]. Sci Rep202010(1): 6633.
[21]
Qian YLiu HPan J,et al. Preoperative Controlling Nutritional Status(CONUT)score predicts short-term outcomes of patients with gastric cancer after laparoscopy-assisted radical gastrectomy[J]. World J Surg Oncol202119(1): 25.
[22]
Yamamoto MSaito HUejima C,et al. Prognostic Value of Combined Tumor Marker and Controlling Nutritional Status(CONUT)Score in Colorectal Cancer Patients[J]. Yonago Acta Med201962(1): 124-130.
[23]
Sheng RKim HLee H,et al. Cholesterol selectively activates canonical Wnt signalling over non-canonical Wnt signalling[J]. Nat Commun20145: 4393.
[24]
Oneyama CIino TSaito K,et al. Transforming potential of Src family kinases is limited by the cholesterol-enriched membrane microdomain[J]. Mol Cell Biol200929(24): 6462-6472.
[25]
Yang WBai YXiong Y,et al. Potentiating the antitumour response of CD8(+)T cells by modulating cholesterol metabolism[J]. Nature2016531(7596): 651-655.
[26]
Jafri SHShi RMills G. Advance lung cancer inflammation index(ALI)at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer(NSCLC): a retrospective review[J]. BMC Cancer201313: 158.
[27]
Barth DABrenner CRiedl JM,et al. External validation of the prognostic relevance of the advanced lung cancer inflammation index(ALI)in pancreatic cancer patients[J]. Cancer Med20209(15): 5473-5479.
[28]
Chen WZheng RBaade PD,et al. Cancer statistics in China,2015[J]. CA Cancer J Clin201666(2): 115-132.
[29]
赵玉沛,邱江东. 中国腹腔镜胰腺癌根治术:20年回顾与展望[J/CD].中华普外科手术学杂志(电子版)202115(03): 237-240.
[30]
La Torre MZiparo VNigri G,et al. Malnutrition and pancreatic surgery: prevalence and outcomes[J]. J Surg Oncol2013107(7): 702-708.
[31]
Sagar RCKumar KVVRamachandra C,et al. Perioperative Artificial Enteral Nutrition in Malnourished Esophageal and Stomach Cancer Patients and Its Impact on Postoperative Complications[J]. Indian J Surg Oncol201910(3): 460-464.
[32]
Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill[J]. Bratisl Lek Listy2001102(1): 5-14.
[33]
Kanda MFujii TKodera Y,et al. Nutritional predictors of postoperative outcome in pancreatic cancer[J]. Br J Surg201198(2): 268-274.
[34]
Sugimachi KIguchi TMano Y,et al. The Impact of Immunonutritional and Physical Status on Surgical Outcome After Pancreaticoduodenectomy in Elderly Patients[J]. Anticancer Res201939(11): 6347-6353.
[35]
李浩,王飞通,王聪,等. 预后营养指数对远端胰腺切除术后临床相关胰瘘的影响及其相关因素分析[J]. 中国普外基础与临床杂志202229(02): 211-217.
[36]
Rungsakulkij NTangtawee PSuragul W,et al. Correlation of serum albumin and prognostic nutritional index with outcomes following pancreaticoduodenectomy[J]. World J Clin Cases20197(1): 28-38.
[37]
Utsumi MAoki HNagahisa S,et al. Preoperative predictive factors of pancreatic fistula after pancreaticoduodenectomy: usefulness of the CONUT score[J]. Ann Surg Treat Res202099(1): 18-25.
[38]
Shiihara MHiguchi RIzumo W,et al. Impact of the controlling nutritional status score on severe postoperative complications of pancreaticoduodenectomy for pancreatic cancer[J]. Langenbecks Arch Surg2021406(5): 1491-1498.
[39]
Kato YYamada SSuenaga M,et al. Impact of the Controlling Nutritional Status Score on the Prognosis After Curative Resection of Pancreatic Ductal Adenocarcinoma[J]. Pancreas201847(7): 823-829.
[40]
潘浩,江斌,王健,等. 术前格拉斯哥预后评分和控制营养评分对胰十二指肠切除术后严重并发症的预测价值[J]. 临床外科杂志202129(12): 1147-1150.
[41]
Horino TTokunaga RMiyamoto Y,et al. The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection[J]. Ann Gastroenterol Surg20226(1): 83-91.
[42]
Xie HHuang SYuan G,et al. The advanced lung cancer inflammation index predicts short and long-term outcomes in patients with colorectal cancer following surgical resection: a retrospective study[J]. Peer J20208: e10100.
[43]
Houghton AMRzymkiewicz DMJi H,et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth[J]. Nat Med201016(2): 219-223.
[44]
De Larco JEWuertz BRFurcht LT. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8[J]. Clin Cancer Res200410(15): 4895-4900.
[45]
斯莹,肖科,孙长峰,等. 中性粒细胞与淋巴细胞比值联合系统免疫炎症指数评价乙肝相关肝细胞癌切除术后预后的价值[J]. 中国普外基础与临床杂志202128(08): 1056-1061.
[46]
Takeuchi MHoshino SKawakubo H,et al. Author Reflections: Relationship of Systemic Inflammatory Response Indicators at Recurrence to Long-Term Outcomes in Patients with Recurrent Esophageal Squamous Cell Carcinoma: The Utility of Neutrophil-to-Lymphocyte Ratio[J]. Ann Surg Oncol202128(6): 3009-3010.
[47]
毕兰青,张勤英,朱凡,等. 中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及预后营养指数与晚期肺腺癌患者临床疗效及5年预后的关系研究[J]. 实用心脑肺血管病杂志202129(01): 45-50.
[48]
朱子毓,汪亦民,李凤科,等. 血小板与淋巴细胞比值和中性粒细胞与淋巴细胞比值对TNMI至Ⅲ期胃癌患者的预后评估[J]. 中华消化杂志202040(02): 93-98.
[49]
Aziz MHSideras KAziz NA,et al. The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels: A Retrospective Multicenter Cohort Study[J]. Ann Surg2019270(1): 139-146.
[50]
Murthy PZenati MSAl Abbas AI,et al. Prognostic Value of the Systemic Immune-Inflammation Index(SII)After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer[J]. Ann Surg Oncol202027(3): 898-906.
[51]
Liu JJiang SYang X,et al. The Significant Value of Preoperative Prognostic Nutritional Index for Survival in Pancreatic Cancers: A Meta-analysis[J]. Pancreas201847(7): 793-799.
[52]
Li STian GChen Z,et al. Prognostic Role of the Prognostic Nutritional Index in Pancreatic Cancer: A Meta-analysis[J]. Nutr Cancer201971(2): 207-213.
[53]
Zhao PWu ZWang Z,et al. Prognostic role of the prognostic nutritional index in patients with pancreatic cancer who underwent curative resection without preoperative neoadjuvant treatment: A systematic review and meta-analysis[J]. Front Surg20229: 992641.
[54]
Wang ASun BWang M,et al. Predictive value of CONUT score combined with serum CA199 levels in postoperative survival of patients with pancreatic ductal adenocarcinoma: a retrospective study[J]. PeerJ20208: e8811.
[55]
Ma XZou WSun Y. Prognostic Value of Pretreatment Controlling Nutritional Status Score for Patients With Pancreatic Cancer: A Meta-Analysis[J]. Front Oncol202111: 770894.
[56]
Dang CWang MZhu F,et al. Controlling nutritional status(CONUT)score-based nomogram to predict overall survival of patients with pancreatic cancer undergoing radical surgery[J]. Asian J Surg202245(6): 1237-1245.
[57]
Terasaki FSugiura TOkamura Y,et al. The preoperative controlling nutritional status(CONUT)score is an independent prognostic marker for pancreatic ductal adenocarcinoma[J]. Updates Surg202173(1): 251-259.
[58]
Topkan EMertsoylu HOzdemir Y,et al. Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy[J]. Cancer Manag Res201911: 8807-8815.
[59]
Hua XChen JWu Y,et al. Prognostic role of the advanced lung cancer inflammation index in cancer patients: a meta-analysis[J]. World J Surg Oncol201917(1): 177.
[60]
Liu XRWang LLZhang B,et al. The advanced lung cancer inflammation index is a prognostic factor for gastrointestinal cancer patients undergoing surgery: a systematic review and meta-analysis[J]. World J Surg Oncol202321(1): 81.
[61]
Zhang LZhao KKuang T,et al. The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy[J]. BMC Cancer202323(1): 101.
[1] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[2] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[3] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[7] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[8] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[9] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[10] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[11] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[12] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[13] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[14] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[15] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
阅读次数
全文


摘要